Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13969445 | 0.81 | ALDH1A1 (0.42) | ALDH1A1KDM4EMAPTHPGDKMT2A | |
| Trifluoromethanesulfonic Acid SCHEMBL30596399 | 0.79 | KCNH2 (0.31) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL30596403 | 0.76 | GPR3 (0.31) | — | |
| SCHEMBL27669843 | 0.72 | — | — | |
| SCHEMBL28408945 | 0.66 | PPM1B (0.40) | ALDH1A1KDM4ELMNA | |
| SCHEMBL28923743 | 0.66 | ALDH1A1 (0.42) | ALDH1A1KDM4EMAPTHPGDKMT2A | |
| SCHEMBL28409269 | 0.66 | ALDH1A1 (0.42) | ALDH1A1KDM4EMAPTHPGDKMT2A | |
| SCHEMBL6316661 | 0.66 | ALDH1A1 (0.42) | ALDH1A1KDM4EMAPTHPGDKMT2A | |
| SCHEMBL3000733 | 0.65 | PPM1B (0.38) | ALDH1A1KDM4EMAPTHPGDLMNA | |
| Trifluoromethanesulfonic Acid SCHEMBL1138043 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195463-A1 | ORGANOMETALLIC COMPLEX, CONTROLLED-RELEASE MULTI-FUNCTIONAL DRUG, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE | FACULDADE DE CIENCIAS DA UNIV DE LISBOA (PT) | 2025-06-19 | — | — | US | disclosed |
| EP-4508058-A1 | ORGANOMETALLIC COMPLEX, CONTROLLED-RELEASE MULTI-FUNCTIONAL DRUG, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE | Faculdade de Ciencias da Universidade de Lisboa (PT) | 2025-02-19 | — | — | EP | disclosed |
| WO-2023199134-A1 | ORGANOMETALLIC COMPLEX, CONTROLLED-RELEASE MULTI-FUNCTIONAL DRUG, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE | FACULDADE DE CIÊNCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195463-A1 | ORGANOMETALLIC COMPLEX, CONTROLLED-RELEASE MULTI-FUNCTIONAL DRUG, PHARMACEUTICAL COMPOSITION, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE | SAMM50, CYP4F2, ABCB1 | ALDH1A1 1096/4885KDM4E 740/4885MAPT 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.